GD3S and GD317 as well as O-acetyl-GD217 were found to drive glioblastoma CSCs and tumorigenicity, with anti-O-acetyl-GD2 antibody sensitization of tumor cells to temozolomide in vitro and in vivo. This evidence concerns the gene ST8SIA1 and neoplasm.